Medicine and Dentistry
Patient
100%
Haemophilia
88%
Therapeutic Procedure
76%
Prophylaxis
46%
Bleeding
22%
Patient with Hemophilia
19%
Quality of Life
18%
Health
18%
Age
16%
Person
14%
Adult
13%
Child
12%
Development
11%
Disease
11%
Substitution Therapy
11%
Surgery
10%
Hemostat
10%
Thrombin
8%
Immunological Tolerance
7%
Thrombosis
7%
Association
7%
Life
7%
Blood Clotting Factor
7%
Health Care Cost
6%
Symptom
6%
Experience
6%
Cardiovascular Disease
5%
Drug Megadose
5%
Follow up
5%
Pharmacology, Toxicology and Pharmaceutical Science
Blood Clotting Factor 8
43%
Haemophilia A
34%
Pharmacokinetics
28%
Von Willebrand Factor
22%
Von Willebrand Disease
22%
Replacement Therapy
17%
Ciclonicate
15%
Hemostatic Agent
12%
Blood Clotting Factor 8 Plus Von Willebrand Factor
9%
Activated Prothrombin Complex
9%
Warfarin
8%
Antibodies
6%
Prospective Study
6%
Incidence
6%
Recombinant Blood Clotting Factor 8
5%
Anticoagulant Agent
5%
